IVUPDATE from IVTEAM

IVTEAM is a global resource for vascular access and infusion therapy, dedicated to supporting clinical teams worldwide. Our daily updates help healthcare professionals stay current with the latest evidence in vascular access and infusion therapy.

Tunneled central venous catheters for home hemodialysis – Full Text

“An expert panel of clinicians was convened by Outset Medical, a manufacturer of hemodialysis systems, to review the literature and generate consensus recommendations regarding the use of CVCs for HHD. Consistent with the most recent Kidney Disease Outcomes vascular access guidelines, the end-stage kidney disease life plan should be created via shared decision making for modality choices, with the corresponding dialysis access individualized for the patient, and for whom a CVC may represent the most appropriate vascular access to provide HHD” Aragon et al (2024).

Read More »

PICC outcomes in hematological cancer patients – Full Text

“This review aimed to examine if there is any difference in the risk of thrombosis and central line-associated bloodstream infection (CLABSI) with the use of peripherally inserted central catheter (PICC) and conventional central venous catheters (CVC) in hematological cancer patients” Ge and Zheng (2025).

Read More »

CRBSI among hemodialysis patients – Full Text

“Over 50% of patients developed CRBSI and gram-positive bacteria were the major causative bacteria. Associated factors were multifactorial and preventive care would be ideal to reduce the number of CRBSI based on these findings” Costantine et al (2025).

Read More »

Vascular access device complications in pregnancy

“The objectives are 3-fold: (1) discuss indications and contraindications, approach to placement, and associated complications for PICC lines, arterial catheters, centrally inserted central catheters, and peripheral intravenous catheters; (2) review available data regarding complications associated with these catheters in pregnancy; and (3) propose an evidence-based approach to clinical decision making regarding vascular access in 2 clinical scenarios among pregnant patients” Sarosi et al (2025).

Read More »

Repeated peripheral IV catheterization in neonates

“The aim of this study was describe the clinical characteristics of neonates requiring multiple PIVCs during hospitalization. A secondary case series of neonates requiring three or more PIVCs during their admission were identified from a cohort admitted to an Australian Neonatal Unit between October 2020 and February 2021” Hall et al (2025).

Read More »

Home intravenous diuretic administration for heart failure – Full Text

“Intravenous (IV) diuretic administration is essential for treating worsening HF. Emerging strategies include home-based IV diuretic therapy administration; however, limited practical implementation guidance is available. This scoping review aims to summarize the literature on home IV diuretic administration for HF patients, focusing on the interventions’ characteristics, and facilitators and barriers to its implementation” Krauter et al (2025).

Read More »

Red blood cell transfusions in NICU

“Large variation in transfusion practice remains between Dutch NICUs despite a national guideline. Extreme prematurity and cumulative blood draws were associated with increased use of RBC transfusions” Heeger et al (2025).

Read More »

Enhanced adult DIVA score in an emergency department

“The EA-DIVA scale, originally validated in a preoperative setting, was effectively implemented for the first time in the ED. This study established a lower cutoff score for expert intervention utilizing ultrasound guidance compared with previous applications of the EA-DIVA scale” Petta et al (2025).

Read More »

Algorithm to reduce blood culture false positives

“Overusing blood cultures (BCxs) can lead to false positives, unnecessary antibiotics, and increased healthcare costs. Despite studies on inpatient BCx algorithms, none have focused on cardiothoracic surgery (CTS) patients, with complex postoperative care and invasive devices” Seidelman et al (2024).

Read More »

Oral vancomycin induced flushing syndrome – Full Text

“Oral vancomycin is a first-line treatment for CDI. Vancomycin has been widely reported to induce flushing syndrome (also known as Red man syndrome), a well-known hypersensitivity reaction mostly occurs after intravenous administration. However, a few cases of flushing syndrome due to oral vancomycin have been reported” Zeng et al (2024).

Read More »